ImmunityBio, Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ImmunityBio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • ImmunityBio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$80.3M, a 0.15% decline year-over-year.
  • ImmunityBio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$360M, a 0.44% increase year-over-year.
  • ImmunityBio, Inc. annual Operating Income (Loss) for 2023 was -$362M, a 3.12% decline from 2022.
  • ImmunityBio, Inc. annual Operating Income (Loss) for 2022 was -$351M, a 6.36% decline from 2021.
  • ImmunityBio, Inc. annual Operating Income (Loss) for 2021 was -$330M, a 49.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$362M -$11M -3.12% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$351M -$21M -6.36% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$330M -$109M -49.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 -$221M -$64.6M -41.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$156M -$57.9M -58.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$98.4M +$731K +0.74% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
2017 -$99.1M +$25.4M +20.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-25
2016 -$125M +$114M +47.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 -$239M -$233M -4185% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$5.58M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.